Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vallin

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Pacing and Clinical Electrophysiology : PACE|April 1, 1993
Choosing the stimulation rate in patients with intermittent bradycardia and a single lead pacemakerM Rosenqvist, O K Edhag, H Lagergren, et al.
Scandinavian Journal of Immunology|March 21, 2002
Importance of CpG dinucleotides in activation of natural IFN-alpha-producing cells by a lupus-related oligodeoxynucleotideM Magnusson, S Magnusson, H Vallin, et al.
British Heart Journal|October 1, 1984
Pacemaker dependence in patients with bifascicular block during acute anterior myocardial infarctionO Edhag, L Bergfeldt, N Edvardsson, et al.
Journal of Cardiovascular Electrophysiology|February 1, 1996
Sinus node recovery time assessment revisited: role of pharmacologic blockade of the autonomic nervous systemL Bergfeldt, H Vallin, M Rosenqvist, et al.
Journal of Cardiovascular Pharmacology|October 1, 1995
Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordingsB Darpö, H Vallin, O Almgren, et al.
Journal of Autoimmunity|November 6, 1998
Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cellsB Cederblad, S Blomberg, H Vallin, et al.
Acta Medica Scandinavica|January 1, 1987
Prognosis and clinical follow-up of patients resuscitated from out-of hospital cardiac arrestJ Jakobsson, O Nyquist, N Rehnqvist, et al.
Lupus|February 24, 2001
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodiesA A Bengtsson, G Sturfelt, L Truedsson, et al.
The New England Journal of Medicine|November 13, 1975
Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarctionJ S Borer, D R Redwood, B Levitt, et al.
Pacing and Clinical Electrophysiology : PACE|May 30, 1998
Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective studyB Houltz, B Darpö, N Edvardsson, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Pacing and Clinical Electrophysiology : PACE|April 1, 1993
Choosing the stimulation rate in patients with intermittent bradycardia and a single lead pacemakerM Rosenqvist, O K Edhag, H Lagergren, et al.
Scandinavian Journal of Immunology|March 21, 2002
Importance of CpG dinucleotides in activation of natural IFN-alpha-producing cells by a lupus-related oligodeoxynucleotideM Magnusson, S Magnusson, H Vallin, et al.
British Heart Journal|October 1, 1984
Pacemaker dependence in patients with bifascicular block during acute anterior myocardial infarctionO Edhag, L Bergfeldt, N Edvardsson, et al.
Journal of Cardiovascular Electrophysiology|February 1, 1996
Sinus node recovery time assessment revisited: role of pharmacologic blockade of the autonomic nervous systemL Bergfeldt, H Vallin, M Rosenqvist, et al.
Journal of Cardiovascular Pharmacology|October 1, 1995
Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordingsB Darpö, H Vallin, O Almgren, et al.
Journal of Autoimmunity|November 6, 1998
Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cellsB Cederblad, S Blomberg, H Vallin, et al.
Acta Medica Scandinavica|January 1, 1987
Prognosis and clinical follow-up of patients resuscitated from out-of hospital cardiac arrestJ Jakobsson, O Nyquist, N Rehnqvist, et al.
Lupus|February 24, 2001
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodiesA A Bengtsson, G Sturfelt, L Truedsson, et al.
The New England Journal of Medicine|November 13, 1975
Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarctionJ S Borer, D R Redwood, B Levitt, et al.
Pacing and Clinical Electrophysiology : PACE|May 30, 1998
Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective studyB Houltz, B Darpö, N Edvardsson, et al.
Pageof 4